Annual Total Long Term Liabilities
$6.14 B
+$14.88 M+0.24%
December 31, 2023
Summary
- As of February 11, 2025, RPRX annual total long term liabilities is $6.14 billion, with the most recent change of +$14.88 million (+0.24%) on December 31, 2023.
- During the last 3 years, RPRX annual total long term liabilities has risen by +$319.60 million (+5.49%).
- RPRX annual total long term liabilities is now -13.53% below its all-time high of $7.10 billion, reached on December 31, 2021.
Performance
RPRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$6.62 B
-$1.01 B-13.28%
September 30, 2024
Summary
- As of February 11, 2025, RPRX quarterly total long term liabilities is $6.62 billion, with the most recent change of -$1.01 billion (-13.28%) on September 30, 2024.
- Over the past year, RPRX quarterly long term liabilities has increased by +$473.42 million (+7.71%).
- RPRX quarterly long term liabilities is now -13.28% below its all-time high of $7.63 billion, reached on June 30, 2024.
Performance
RPRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RPRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.2% | +7.7% |
| 3 y3 years | +5.5% | +7.7% |
| 5 y5 years | -1.6% | - |
RPRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.5% | +0.2% | -13.3% | +8.1% |
| 5 y | 5-year | -13.5% | +5.5% | -13.3% | +14.6% |
| alltime | all time | -13.5% | +5.5% | -13.3% | +14.6% |
Royalty Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.62 B(-13.3%) |
| Jun 2024 | - | $7.63 B(+24.2%) |
| Mar 2024 | - | $6.14 B(+0.1%) |
| Dec 2023 | $6.14 B(+0.2%) | $6.14 B(-0.1%) |
| Sep 2023 | - | $6.14 B(+0.1%) |
| Jun 2023 | - | $6.14 B(+0.0%) |
| Mar 2023 | - | $6.14 B(+0.2%) |
| Dec 2022 | $6.12 B | $6.12 B(-0.1%) |
| Sep 2022 | - | $6.12 B(-14.3%) |
| Jun 2022 | - | $7.15 B(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.10 B(+0.1%) |
| Dec 2021 | $7.10 B(+22.0%) | $7.10 B(+0.1%) |
| Sep 2021 | - | $7.09 B(+21.7%) |
| Jun 2021 | - | $5.83 B(+0.1%) |
| Mar 2021 | - | $5.82 B(+0.1%) |
| Dec 2020 | $5.82 B(-2.7%) | $5.82 B(-1.8%) |
| Sep 2020 | - | $5.92 B(+1.4%) |
| Jun 2020 | - | $5.84 B(+1.1%) |
| Mar 2020 | - | $5.77 B(-3.3%) |
| Dec 2019 | $5.98 B(-4.2%) | $5.98 B |
| Dec 2018 | $6.24 B | - |
FAQ
- What is Royalty Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Royalty Pharma?
- What is Royalty Pharma annual total long term liabilities year-on-year change?
- What is Royalty Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Royalty Pharma?
- What is Royalty Pharma quarterly long term liabilities year-on-year change?
What is Royalty Pharma annual total long term liabilities?
The current annual total long term liabilities of RPRX is $6.14 B
What is the all time high annual total long term liabilities for Royalty Pharma?
Royalty Pharma all-time high annual total long term liabilities is $7.10 B
What is Royalty Pharma annual total long term liabilities year-on-year change?
Over the past year, RPRX annual total long term liabilities has changed by +$14.88 M (+0.24%)
What is Royalty Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of RPRX is $6.62 B
What is the all time high quarterly long term liabilities for Royalty Pharma?
Royalty Pharma all-time high quarterly total long term liabilities is $7.63 B
What is Royalty Pharma quarterly long term liabilities year-on-year change?
Over the past year, RPRX quarterly total long term liabilities has changed by +$473.42 M (+7.71%)